Takeda Pharmaceutical
TAK
#491
Rank
โ‚ฌ40.64 B
Marketcap
12,21ย โ‚ฌ
Share price
0.28%
Change (1 day)
-3.90%
Change (1 year)

Revenue for Takeda Pharmaceutical (TAK)

Revenue in 2025 (TTM): โ‚ฌ26.43 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ25.36 Billion. In 2024 the company made a revenue of โ‚ฌ28.75 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ26.55 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Takeda Pharmaceutical from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ26.43 B-8.06%
2024 โ‚ฌ28.75 B8.25%
2023 โ‚ฌ26.55 B-3.87%
2022 โ‚ฌ27.62 B1.22%
2021 โ‚ฌ27.29 B11.18%
2020 โ‚ฌ24.55 B-7.37%
2019 โ‚ฌ26.50 B87.8%
2018 โ‚ฌ14.11 B6.43%
2017 โ‚ฌ13.26 B-12.7%
2016 โ‚ฌ15.19 B9.45%
2015 โ‚ฌ13.87 B4.93%
2014 โ‚ฌ13.22 B9.69%
2013 โ‚ฌ12.05 B-17.16%
2012 โ‚ฌ14.55 B2.28%
2011 โ‚ฌ14.23 B15.04%
2010 โ‚ฌ12.37 B14.08%
2009 โ‚ฌ10.84 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ79.15 B 212.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.82 B 60.94%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
โ‚ฌ53.93 B 112.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.42 B 90.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
โ‚ฌ1.97 B-92.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
โ‚ฌ3.39 B-86.60%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
โ‚ฌ30.89 B 21.81%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.38 B 43.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ55.17 B 117.53%๐Ÿ‡บ๐Ÿ‡ธ USA